174 related articles for article (PubMed ID: 33795829)
21. Squamous cell carcinoma of the anal canal.
Mitchell SE; Mendenhall WM; Zlotecki RA; Carroll RR
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1007-13. PubMed ID: 11240241
[TBL] [Abstract][Full Text] [Related]
22. Combined chemoradiation therapy for anal cancer. A report of 56 cases.
Doci R; Zucali R; Bombelli L; Montalto F; Lamonica G
Ann Surg; 1992 Feb; 215(2):150-6. PubMed ID: 1546901
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group.
Bonin SR; Pajak TF; Russell AH; Coia LR; Paris KJ; Flam MS; Sauter ER
Cancer; 1999 Mar; 85(6):1226-33. PubMed ID: 10189126
[TBL] [Abstract][Full Text] [Related]
24. [Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Pène F; Schlienger M
Cancer Radiother; 2003 Aug; 7(4):237-53. PubMed ID: 12914857
[TBL] [Abstract][Full Text] [Related]
25. Mitomycin and 5-fluorouracil for second-line treatment of metastatic squamous cell carcinomas of the anal canal.
Saint A; Evesque L; Falk AT; Cavaglione G; Montagne L; Benezery K; Francois E
Cancer Med; 2019 Nov; 8(16):6853-6859. PubMed ID: 31524335
[TBL] [Abstract][Full Text] [Related]
26. Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281).
Meropol NJ; Niedzwiecki D; Shank B; Colacchio TA; Ellerton J; Valone F; Budinger S; Day JM; Hopkins J; Tepper J; Goldberg RM; Mayer RJ
J Clin Oncol; 2008 Jul; 26(19):3229-34. PubMed ID: 18490648
[TBL] [Abstract][Full Text] [Related]
27. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
[TBL] [Abstract][Full Text] [Related]
28. Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen study.
Siegel EM; Eschrich S; Winter K; Riggs B; Berglund A; Ajidahun A; Simko J; Moughan J; Ajani J; Magliocco A; Elahi A; Hoffe S; Shibata D
Dis Colon Rectum; 2014 Aug; 57(8):941-57. PubMed ID: 25003289
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor receptor inhibition in metastatic anal cancer.
Rogers JE; Ohinata A; Silva NN; Mehdizadeh A; Eng C
Anticancer Drugs; 2016 Sep; 27(8):804-8. PubMed ID: 27272412
[TBL] [Abstract][Full Text] [Related]
30. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
[TBL] [Abstract][Full Text] [Related]
31. Induction chemotherapy followed by radiotherapy in the treatment of anal cancer.
Lee DH; Kim I; Song HH; Jung JY; Kim DY; Lee KW; Kim TY; Heo DS; Bang YJ; Ha SW; Park JG; Kim NK
Oncol Rep; 2003; 10(1):101-4. PubMed ID: 12469152
[TBL] [Abstract][Full Text] [Related]
32. [Radiochemotherapy in anal canal epidermoid cancer].
Peiffert D
Ann Chir; 2000 Oct; 125(8):717-25. PubMed ID: 11105342
[TBL] [Abstract][Full Text] [Related]
33. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.
Edelman S; Johnstone PA
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):206-11. PubMed ID: 16904522
[TBL] [Abstract][Full Text] [Related]
34. [Rationale and progress of the phase III trial: intensification of the treatment of locally advanced squamous cell carcinoma of the anal canal].
Peiffert D
Cancer Radiother; 2003 Nov; 7 Suppl 1():100s-107s. PubMed ID: 15124551
[TBL] [Abstract][Full Text] [Related]
35. Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular Classification.
Trilla-Fuertes L; Ghanem I; Gámez-Pozo A; Maurel J; G-Pastrián L; Mendiola M; Peña C; López-Vacas R; Prado-Vázquez G; López-Camacho E; Zapater-Moros A; Heredia V; Cuatrecasas M; García-Alfonso P; Capdevila J; Conill C; García-Carbonero R; Ramos-Ruiz R; Fortes C; Llorens C; Nanni P; Fresno Vara JÁ; Feliu J
Mol Cell Proteomics; 2020 Apr; 19(4):690-700. PubMed ID: 32107283
[TBL] [Abstract][Full Text] [Related]
36. Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy.
Chauveinc L; Buthaud X; Falcou MC; Mosseri V; De la Rochefordière A; Pierga JY; Girodet J; Salmon RJ
Br J Cancer; 2003 Dec; 89(11):2057-61. PubMed ID: 14647138
[TBL] [Abstract][Full Text] [Related]
37. Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal.
Kapp KS; Geyer E; Gebhart FH; Oechs AC; Berger A; Hebenstreit J; Stoeger H
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):997-1005. PubMed ID: 11240240
[TBL] [Abstract][Full Text] [Related]
38. Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients.
Doci R; Zucali R; La Monica G; Meroni E; Kenda R; Eboli M; Lozza L
J Clin Oncol; 1996 Dec; 14(12):3121-5. PubMed ID: 8955657
[TBL] [Abstract][Full Text] [Related]
39. EGFR Inhibitors in Patients with Advanced Squamous Cell Anal Carcinomas: A Single-Institution Experience.
Kim DW; Byer J; Kothari N; Mahipal A; Chang YD; Kim RD
Oncology; 2017; 92(4):190-196. PubMed ID: 28152526
[TBL] [Abstract][Full Text] [Related]
40. Chemoradiotherapy of anal carcinoma: tumour response and acute toxicity.
Tanum G; Tveit KM; Karlsen KO
Oncology; 1993; 50(1):14-7. PubMed ID: 8421594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
